Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2019–2026
Update Available On-Demand

A00556
Pages: 742
Oct 2019 | 22985 Views
 
Author(s) : Surabhi Pandey , Onkar Sumant
Tables: 526
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ivf Services Market

Request Now !

IVF Services Market Outlook - 2026

The global In vitro fertilization services market size generated $12,506 million in 2018, and is projected to reach $25,563 million by 2026, growing at a CAGR of 9.3% from 2019 to 2026.

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm in vitro. The process involves stimulating a woman's ovulatory, removing an ovum from the woman's ovaries, and letting sperm fertilize them in a liquid in a laboratory. IVF is one of the widely used treatments to assist couples with infertility issues, which is a key factor that drives the growth of the IVF services Market globally.

IVF Service Market

Get more information on this report : Request Sample Pages

The global In vitro fertilization services market is anticipated to exhibit significant growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost & complications associated with IVF treatment and low awareness for IVF in underdeveloped regions hinder the growth of the IVF services market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and low cost of IVF services in developing countries as compared to developed countries are expected to offer remunerative opportunities for market expansion.

Cycle type segment review

The cycle type segment is classified into fresh (non-donor) IVF cycles, thawed (non-donor) IVF cycles, and donor egg IVF cycles. The fresh IVF cycles (non-donor) was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to higher success rate, as fresh embryo transfers lead to better pregnancy and birth rates compared to those who received frozen embryos.

IVF Services Market
By Cycle Type

Your browser does not support the canvas element.

Fresh Cycle holds the dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

End user segment review

Depending on end user, the In vitro fertilization services market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. The clinical research institutes segment is projected to exhibit the highest growth during the forecast period. This is attributed to the fact that majority of the research on fertility problems and their possible treatments, including IVF are carried out in clinical research institutes. In addition, technological advancement in IVF devices and services is the major driving factor for the growth of the IVF clinical research institutes segment. However, fertility clinics and specialty hospitals play a crucial role in providing IVF treatments to couples seeking assistance for infertility treatments. In addition, availability of a wide range of fertility treatments under one roof coupled with government reimbursements majorly drive the growth of fertility clinic segment.

IVF Services Market
By End User

Your browser does not support the canvas element.

Clinical Research Institutes segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Region segment review

Region wise, the IVF services market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest market share in 2018, and is expected to retain its dominance throughout the forecast period. This is attributed to presence of high population base in countries such as India & China, increase in awareness about IVF treatment, low costs of IVF treatments, rise in number of infertile population, and surge in disposable income.

IVF Services Market
By Region

2026
Asia-pacific 
North America
Europe
Lamea

Asia-Pacific region would exhibit the highest CAGR of 12.0% during 2019-2026.

Get more information on this report : Request Sample Pages

The key players profiled in the global IVF industry include Ambroise Paré Group, amedes MVZ Cologne GmbH, AMP Center St Roch, AVA Clinic Scanfert, Bangkok IVF Center, Bangkok IVF center (Bangkok Hospital), Betamedics, Biofertility Center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bourn Hall International, Cardone Reproductive Medicine and Infertility, LLC, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chelsea and Westminster Hospital (Assisted Conception Unit), Cloudnine Fertility, Conceptions Reproductive Associates of Colorado, Cyprus IVF Centre, Dansk Fertilitetsklinik, EUVITRO S.L.U., Fakih IVF Fertility Center, Fertility and Gynecology Center Monterey Bay IVF, Fertility Associates, Fertility Center Berlin, Fertility Center of San Antoni, Fertility First, FIV Marbella, Fivet Centers Prof. Zech, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, Heidelberg University Hospital, Houston Fertility Center, International Centre for Reproductive Medicine, ICRM, IVF Canada, IVF NAMBA Clinic, IVF Panama Center for Reproduction Punta Pacífica, IVF Spain, IVI Panama, Ivinsemer, KL Fertility & Gynaecology Centre, Lifesure Fertility and Gynaecology Centre, LIV Fertility Center, Manipal Fertility, Maria Fertility Hospital, MD Medical Group, Medfem Fertility Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., New hope fertility center, Oak Medical Group/Oak Clinic, OVA IVF Clinic Zurich, Procrea Fertility, RAPRUI Srl, Repromed, SAFE Fertility Center, Sanno Hospital, Servy Massey Fertility Institute, Shanghai Ji Ai Genetics & IVF Institute, Shanghai United Family Hospital, Sher Institute for Reproductive Medicine (SIRM), Southend Fertility and IVF, StorkKlinik (Stork IVF Clinic), The ARC-STER Center, The Bridge Centre, The Cape Fertility Clinic, The Hugh Wynter Fertility Management Unit, The Lister Fertility Clinic, The Montreal Fertility Center, Thomson Medical Pte. Ltd., Trianglen Fertility Clinic, TRIO Fertility, Virtus Health, Vitanova, VivaNeo - Medical Center Kinderwens, and Wunschkinder.

Key Benefits for IVF Services Market:

  • The study provides an in-depth IVF services market analysis with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing IVF services market size.
  • Comprehensive analysis of all regions is provided to determine the In vitro fertilization services market forecast.
  • Key players are profiled to understand the competitive outlook of the global IVF services market share.

IVF Services Market Segments:

By Cycle Type

  • Fresh IVF Cycles (Non-donor)
  • Thawed IVF Cycles (Non-donor)
  • Donor Egg IVF Cycles

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Denmark
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • Australia
    • India
    • South Korea
    • New Zealand
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

CHAPTER 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. IVF pricing trends
3.3. IVF Cycles by Country
3.4. Global IVF services market, by end user

3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.4.3. Fertility clinics

3.4.3.1. Market size and forecast

3.4.4. Hospitals

3.4.4.1. Market size and forecast

3.4.5. Surgical centers

3.4.5.1. Market size and forecast

3.4.6. Clinical research institutes

3.4.6.1. Market size and forecast

3.5. Global IVF services market by cycle type

3.5.1. Market size and forecast
3.5.2. Market volume and forecast
3.5.3. Fresh IVF cycles (non-donor)

3.5.3.1. Market size and forecast

3.5.4. Thawed IVF cycles (non-donor)

3.5.4.1. Market size and forecast

3.5.5. Donor egg IVF cycles

3.5.5.1. Market size and forecast

3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Delayed pregnancies in women
3.6.1.2. Increase in global infertility rates
3.6.1.3. Increase in gamete donations
3.6.1.4. Increase in disposable income
3.6.1.5. Increase in IVF success rates
3.6.1.6. Surge in healthcare expenditure worldwide

3.6.2. Restraints

3.6.2.1. Cost constraints
3.6.2.2. Complications associated with IVF treatment
3.6.2.3. Low awareness level

3.6.3. Opportunities

3.6.3.1. Fertility tourism
3.6.3.2. Growth opportunities in the emerging markets
3.6.3.3. Increase in number of fertility clinics
3.6.3.4. Rise in same sex marriage

3.6.4. Impact analyses

3.7. Key findings

CHAPTER 4: NORTH AMERICA IVF SERVICES MARKET

4.1. Overview

4.1.1. Market size and forecast

4.1.1.1. By country
4.1.1.2. By End User
4.1.1.3. By Cycle Type

4.1.2. Market volume and forecast

4.1.2.1. By Country
4.1.2.2. By End User
4.1.2.3. By Cycle Type

4.2. U.S. IVF services market, (Revenue and Number of Cycles)

4.2.1. Overview
4.2.2. Market size and forecast
4.2.3. Fertility Clinics in U.S., 2016
4.2.4. U.S. IVF services market, by end user

4.2.4.1. Market size and forecast
4.2.4.2. Market volume and forecast
4.2.4.3. Fertility clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical Centers
4.2.4.6. Clinical Research Institutes

4.2.5. U.S. IVF services market, by cycle type

4.2.5.1. Market size and forecast
4.2.5.2. Market volume and forecast
4.2.5.3. Fresh IVF cycles (non-donor)
4.2.5.4. Thawed IVF cycles (non-donor)
4.2.5.5. Donor egg IVF cycles

4.2.6. Market dynamics

4.2.6.1. Driving factors

4.2.6.1.1. Increasing popularity of IVF in U.S.
4.2.6.1.2. Increased rate of infertility and practices of embryo banking cycles

4.2.6.2. Restraining Factors

4.2.6.2.1. High cost of IVF treatment in U.S.
4.2.6.2.2. Restrictions on 3-parent IVF treatments
4.2.6.2.3. Scattered Reimbursements

4.2.7. Regulatory Issues, Legislations and Authorities
4.2.8. Insurance Reimbursement Scenario
4.2.9. Company Profiles

4.2.9.1. Fertility and Gynecology Center Monterey Bay IVF

4.2.9.1.1. Company overview

4.2.9.2. Conceptions Reproductive Associates of Colorado

4.2.9.2.1. Company overview

4.2.9.3. Servy Massey Fertility Institute

4.2.9.3.1. Company overview

4.2.9.4. Sher Institute for Reproductive Medicine (SIRM)

4.2.9.4.1. Company overview

4.2.9.5. Cardone Reproductive Medicine and Infertility, LLC

4.2.9.5.1. Company overview

4.2.9.6. Fertility Center of San Antoni

4.2.9.6.1. Company overview

4.2.9.7. Houston Fertility Center

4.2.9.7.1. Company overview

4.2.9.8. New hope fertility center

4.2.9.8.1. Company overview

4.3. Canada IVF services market, (Revenue and Number of Cycles)

4.3.1. Overview
4.3.2. Market size and forecast
4.3.3. IVF Clinics in Canada

4.3.4. Canada IVF services market, by end user

4.3.4.1. Market size and forecast
4.3.4.2. Market volume and forecast
4.3.4.3. Fertility clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical Centers
4.3.4.6. Clinical Research Institutes

4.3.5. Canada IVF services market, by cycle type

4.3.5.1. Market size and forecast
4.3.5.2. Market volume and forecast
4.3.5.3. Fresh IVF cycles (non-donor)
4.3.5.4. Thawed IVF cycles (non-donor)
4.3.5.5. Donor egg IVF cycles

4.3.6. Market Dynamics

4.3.6.1. Driving Factors

4.3.6.1.1. Commercialization of IVF booster in Canada

4.3.6.2. Restraining Factors

4.3.6.2.1. High cost of IVF treatment in Canada

4.3.7. Regulatory Issues, Legislations and Authorities
4.3.8. Insurance Reimbursement Scenario
4.3.9. Company Profiles

4.3.9.1. TRIO Fertility

4.3.9.1.1. Company overview

4.3.9.2. The Montreal Fertility Center

4.3.9.2.1. Company overview

4.3.9.3. Procrea Fertility

4.3.9.3.1. Company overview

4.3.9.4. IVF Canada

4.3.9.4.1. Company overview

4.4. Mexico IVF services market, (Revenue and Number of Cycles)

4.4.1. Overview
4.4.2. Market size and forecast
4.4.3. Fertility Clinics in Mexico
4.4.4. Mexico IVF services market, by end user

4.4.4.1. Market size and forecast
4.4.4.2. Market volume and forecast
4.4.4.3. Fertility clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical Centers
4.4.4.6. Clinical Research Institutes

4.4.5. Mexico IVF services market, by cycle type

4.4.5.1. Market size and forecast
4.4.5.2. Market volume and forecast
4.4.5.3. Fresh IVF cycles (non-donor)
4.4.5.4. Thawed IVF cycles (non-donor)
4.4.5.5. Donor egg IVF cycles

4.4.6. Market Dynamics

4.4.6.1. Driving Factors

4.4.6.1.1. Fertility tourism
4.4.6.1.2. Comparatively low cost of IVF

4.4.6.2. Restraining Factors

4.4.6.2.1. Language Barriers

4.4.7. Regulatory Issues, Legislations and Authorities
4.4.8. Insurance Reimbursement Scenario
4.4.9. Company Profiles

4.4.9.1. LIV Fertility Center

4.4.9.1.1. Company overview

4.4.9.2. Biofertility Center

4.4.9.2.1. Company overview

4.4.9.3. Ivinsemer

4.4.9.3.1. Company overview

CHAPTER 5: EUROPE IVF SERVICES MARKET

5.1. Overview

5.1.1. Market size and forecast

5.1.1.1. By Country
5.1.1.2. By End User
5.1.1.3. By Cycle Type

5.1.2. Market volume and forecast

5.1.2.1. By Country
5.1.2.2. By End User
5.1.2.3. By Cycle Type

5.2. Germany IVF services market, (Revenue and Number of Cycles)

5.2.1. Overview
5.2.2. Market size and forecast
5.2.3. Fertility Clinics in Germany

5.2.4. Germany IVF services market, by end user

5.2.4.1. Market size and forecast
5.2.4.2. Market volume and forecast
5.2.4.3. Fertility clinics

5.2.4.4. Hospitals
5.2.4.5. Surgical Centers
5.2.4.6. Clinical Research Institutes

5.2.5. Germany IVF services market, by cycle type

5.2.5.1. Market size and forecast
5.2.5.2. Market volume and forecast
5.2.5.3. Fresh IVF cycles (non-donor)
5.2.5.4. Thawed IVF cycles (non-donor)

5.2.6. Market dynamics

5.2.6.1. Driving Factors

5.2.6.1.1. Subsidizing IVF treatments
5.2.6.1.2. Delayed marriages and parenthood decisions

5.2.6.2. Restraining Factors

5.2.6.2.1. Limited adoption of IVF methods

5.2.7. Regulatory Issues, Legislations and Authorities
5.2.8. Insurance Reimbursement Scenario
5.2.9. Company Profiles

5.2.9.1. Heidelberg University Hospital

5.2.9.1.1. Company overview

5.2.9.2. Wunschkinder

5.2.9.2.1. Company overview

5.2.9.3. Fertility Center Berlin

5.2.9.3.1. Company overview

5.2.9.4. amedes MVZ Cologne GmbH

5.2.9.4.1. Company overview

5.3. France IVF services market, (Revenue and Number of Cycles)

5.3.1. Overview
5.3.2. Market size and forecast
5.3.3. IVF Clinics in France

5.3.4. France IVF services market, by end user

5.3.4.1. Market size and forecast
5.3.4.2. Market volume and forecast
5.3.4.3. Fertility clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical Centers
5.3.4.6. Clinical Research Institutes

5.3.5. France IVF services market, by cycle type

5.3.5.1. Market size and forecast
5.3.5.2. Market volume and forecast
5.3.5.3. Fresh IVF cycles (non-donor)
5.3.5.4. Thawed IVF cycles (non-donor)
5.3.5.5. Donor egg IVF cycles

5.3.6. Market Dynamics

5.3.6.1. Driving Factors

5.3.6.1.1. Rising adoption of IVF babies among same gender population
5.3.6.1.2. Lower rates of Fertility

5.3.6.2. Restraining Factors

5.3.6.2.1. Stringent government regulations

5.3.7. Regulatory Issues, Legislations and Authorities
5.3.8. Insurance Reimbursement Scenario
5.3.9. Company Profiles

5.3.9.1. Ambroise Par Group

5.3.9.1.1. Company overview

5.3.9.2. AMP Center St Roch

5.3.9.2.1. Company overview

5.4. UK IVF services market, (Revenue and Number of Cycles)

5.4.1. Overview
5.4.2. Market size and forecast
5.4.3. Fertility Clinics in UK
5.4.4. UK IVF services market, by end user

5.4.4.1. Market size and forecast
5.4.4.2. Market volume and forecast
5.4.4.3. Fertility clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical Centers
5.4.4.6. Clinical Research Institutes

5.4.5. UK IVF services market, by cycle type

5.4.5.1. Market size and forecast
5.4.5.2. Market volume and forecast
5.4.5.3. Fresh IVF cycles (non-donor)
5.4.5.4. Thawed IVF cycles (non-donor)
5.4.5.5. Donor egg IVF cycles

5.4.6. Market Dynamics

5.4.6.1. Driving Factors

5.4.6.1.1. Commercialization of three-parent IVF procedures
5.4.6.1.2. Supportive Regulations

5.4.6.2. Restraining Factors

5.4.6.2.1. Ethical considerations

5.4.7. Regulatory Issues, Legislations and Authorities
5.4.8. Insurance Reimbursement Scenario
5.4.9. Company Profiles

5.4.9.1. The Lister Fertility Clinic

5.4.9.1.1. Company overview

5.4.9.2. The Bridge Centre

5.4.9.2.1. Company overview

5.4.9.3. Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4.9.3.1. Company overview

5.5. Italy IVF services market, (Revenue and Number of Cycles)

5.5.1. Overview
5.5.2. Market size and forecast
5.5.3. Italy IVF services market, by end use
r

5.5.3.1. Market size and forecast
5.5.3.2. Market volume and forecast
5.5.3.3. Fertility clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical Centers
5.5.3.6. Clinical Research Institutes

5.5.4. Italy IVF services market, by cycle type

5.5.4.1. Market size and forecast
5.5.4.2. Market volume and forecast
5.5.4.3. Fresh IVF cycles (non-donor)
5.5.4.4. Thawed IVF cycles (non-donor)
5.5.4.5. Donor egg IVF cycles

5.5.5. Market Dynamics

5.5.5.1. Driving Factors

5.5.5.1.1. Rise in medical tourism

5.5.5.2. Restraining Factors

5.5.5.2.1. Ban on Surrogacy

5.5.6. Regulatory Issues, Legislations and Authorities
5.5.7. Insurance Reimbursement Scenario
5.5.8. Company Profiles

5.5.8.1. The ARC-STER Center

5.5.8.1.1. Company overview

5.5.8.2. RAPRUI Srl

5.5.8.2.1. Company overview

5.5.8.3. Fivet Centers Prof. Zech

5.5.8.3.1. Company overview

5.6. Spain IVF services market, (Revenue and Number of Cycles)

5.6.1. Overview
5.6.2. Market size and forecast
5.6.3. Spain IVF services market, by end user

5.6.3.1. Market size and forecast
5.6.3.2. Market volume and forecast
5.6.3.3. Fertility clinics
5.6.3.4. Hospitals
5.6.3.5. Surgical Centers
5.6.3.6. Clinical Research Institutes

5.6.4. Spain IVF services market, by cycle type

5.6.4.1. Market size and forecast
5.6.4.2. Market volume and forecast
5.6.4.3. Fresh IVF cycles (non-donor)
5.6.4.4. Thawed IVF cycles (non-donor)
5.6.4.5. Donor egg IVF cycles

5.6.5. Market Dynamics

5.6.5.1. Driving Factors

5.6.5.1.1. Increase in the number of foreign patients

5.6.5.2. Restraining Factors

5.6.5.2.1. Limited awareness and language barriers

5.6.6. Regulatory Issues, Legislations and Authorities
5.6.7. Insurance Reimbursement Scenario
5.6.8. Company Profiles

5.6.8.1. IVF Spain

5.6.8.1.1. Company overview

5.6.8.2. EUVITRO S.L.U.

5.6.8.2.1. Company overview

5.6.8.3. FIV Marbella

5.6.8.3.1. Company overview

5.7. Denmark IVF services market, (Revenue and Number of Cycles)

5.7.1. Overview
5.7.2. Market size and forecast
5.7.3. Denmark IVF services market, by end user

5.7.3.1. Market size and forecast
5.7.3.2. Market volume and forecast
5.7.3.3. Fertility clinics
5.7.3.4. Hospitals
5.7.3.5. Surgical Centers
5.7.3.6. Clinical Research Institutes

5.7.4. Denmark IVF services market, by cycle type

5.7.4.1. Market size and forecast
5.7.4.2. Market volume and forecast
5.7.4.3. Fresh IVF cycles (non-donor)
5.7.4.4. Thawed IVF cycles (non-donor)
5.7.4.5. Donor egg IVF cycles

5.7.5. Market Dynamics

5.7.5.1. Driving Factors

5.7.5.1.1. Increase in disposable income
5.7.5.1.2. Advances in IVF technology

5.7.5.2. Restraining Factors

5.7.5.2.1. Reimbursement in public clinics only

5.7.6. Regulatory Issues, Legislations and Authorities
5.7.7. Insurance Reimbursement Scenario
5.7.8. Company Profiles

5.7.8.1. Vitanova

5.7.8.1.1. Company overview

5.7.8.2. Dansk Fertilitetsklinik

5.7.8.2.1. Company overview

5.7.8.3. StorkKlinik (Stork IVF Clinic)

5.7.8.3.1. Company overview

5.7.8.4. Trianglen Fertility Clinic

5.7.8.4.1. Company overview

5.8. Russia IVF services market, (Revenue and Number of Cycles)

5.8.1. Overview
5.8.2. Market size and forecast
5.8.3. Russia IVF services market, by end user

5.8.3.1. Market size and forecast
5.8.3.2. Market volume and forecast
5.8.3.3. Fertility clinics
5.8.3.4. Hospitals
5.8.3.5. Surgical Centers
5.8.3.6. Clinical Research Institutes

5.8.4. Russia IVF services market, by cycle type

5.8.4.1. Market size and forecast
5.8.4.2. Market volume and forecast
5.8.4.3. Fresh IVF cycles (non-donor)
5.8.4.4. Thawed IVF cycles (non-donor)
5.8.4.5. Donor egg IVF cycles

5.8.5. Market Dynamics

5.8.5.1. Driving Factors

5.8.5.1.1. Rising popularity of fertility tourism

5.8.5.2. Restraining Factors

5.8.5.2.1. Language barrier

5.8.6. Regulatory Issues, Legislations and Authorities
5.8.7. Insurance Reimbursement Scenario
5.8.8. Company Profiles

5.8.8.1. AVA Clinic Scanfert

5.8.8.1.1. Company overview

5.8.8.2. MD Medical Group

5.8.8.2.1. Company overview

5.8.8.3. International Centre for Reproductive Medicine, ICRM

5.8.8.3.1. Company overview

5.9. Rest of Europe IVF services market, (Revenue and Number of Cycles)

5.9.1. Overview
5.9.2. Market size and forecast
5.9.3. Rest of Europe IVF services market, by end user

5.9.3.1. Market size and forecast
5.9.3.2. Market volume and forecast
5.9.3.3. Fertility clinics
5.9.3.4. Hospitals
5.9.3.5. Surgical Centers
5.9.3.6. Clinical Research Institutes

5.9.4. Rest of Europe IVF services market, by cycle type

5.9.4.1. Market size and forecast
5.9.4.2. Market volume and forecast
5.9.4.3. Fresh IVF cycles (non-donor)
5.9.4.4. Thawed IVF cycles (non-donor)
5.9.4.5. Donor egg IVF cycles

5.9.5. Market Dynamics

5.9.5.1. Driving Factors

5.9.5.1.1. Wide availability of reimbursements
5.9.5.1.2. Changes in Lifestyle

5.9.5.2. Restraining Factors

5.9.6. Regulatory Issues, Legislations and Authorities
5.9.7. Insurance Reimbursement Scenario
5.9.8. Company Profiles

5.9.8.1. Betamedics

5.9.8.1.1. Company overview

5.9.8.2. OVA IVF Clinic Zurich

5.9.8.2.1. Company overview

5.9.8.3. VivaNeo - Medical Center Kinderwens

5.9.8.3.1. Company overview

CHAPTER 6: ASIA- PACIFIC IVF SERVICES MARKET

6.1. Overview

6.1.1. Market size and forecast

6.1.1.1. By Country
6.1.1.2. By End User
6.1.1.3. By Cycle Type

6.1.2. Market volume and forecast

6.1.2.1. By Country
6.1.2.2. By End User
6.1.2.3. By Cycle Type

6.2. India IVF Services Market, (Revenue and Number of Cycles)

6.2.1. Overview
6.2.2. Market size and forecast
6.2.3. Fertility center in India, 2017

6.2.4. India IVF Services Market, by end user

6.2.4.1. Market size and forecast
6.2.4.2. Market volume and forecast
6.2.4.3. Fertility clinics
6.2.4.4. Hospitals
6.2.4.5. Surgical Centers
6.2.4.6. Clinical research institutes

6.2.5. India IVF services market, by cycle type

6.2.5.1. Market size and forecast
6.2.5.2. Market volume and forecast
6.2.5.3. Fresh IVF cycles (non-donor)
6.2.5.4. Thawed IVF cycles (non-donor)
6.2.5.5. Donor egg IVF cycles

6.2.6. Market Dynamics

6.2.6.1. Driving Factors
6.2.6.2. Restraining Factors

6.2.7. Regulatory issues, legislations and authorities
6.2.8. Insurance reimbursement scenario
6.2.9. Company profile

6.2.9.1. Bourn Hall Fertility Center

6.2.9.1.1. Company overview

6.2.9.2. Southend Fertility and IVF

6.2.9.2.1. Company overview

6.2.9.3. Morpheus Life Sciences Pvt. Ltd.

6.2.9.3.1. Company overview

6.2.9.4. Bloom Fertility Center

6.2.9.4.1. Company overview

6.2.9.5. Bloom Fertility and Healthcare

6.2.9.5.1. Company overview

6.2.9.6. Manipal Fertility

6.2.9.6.1. Company overview

6.2.9.7. Cloudnine Fertility

6.2.9.7.1. Company overview

6.3. China IVF Services Market, (Revenue and Number of Cycles)

6.3.1. Overview
6.3.2. Market size and forecast

6.3.3. China IVF Services Market, by end user

6.3.3.1. Market size and forecast
6.3.3.2. Market volume and forecast
6.3.3.3. Fertility clinics
6.3.3.4. Hospitals
6.3.3.5. Surgical Centers
6.3.3.6. Clinical research institutes

6.3.4. China IVF services market, by cycle type

6.3.4.1. Market size and forecast
6.3.4.2. Market volume and forecast
6.3.4.3. Fresh IVF cycles (non-donor)
6.3.4.4. Thawed IVF cycles (non-donor)
6.3.4.5. Donor egg IVF cycles

6.3.5. Market Dynamics

6.3.5.1. Driving Factors
6.3.5.2. Restraining Factors

6.3.6. Regulatory issues, legislations and authorities
6.3.7. Insurance reimbursement scenario
6.3.8. Company profile

6.3.8.1. Shanghai Ji Ai Genetics & IVF Institute

6.3.8.1.1. Company overview

6.3.8.2. Shanghai United Family Hospital

6.3.8.2.1. Company overview

6.4. Japan IVF Services Market, (Revenue and Number of Cycles)

6.4.1. Overview
6.4.2. Market size and forecast
6.4.3. Japan IVF services Market, by end user

6.4.3.1. Market size and forecast
6.4.3.2. Market volume and forecast
6.4.3.3. Fertility clinics

6.4.3.4. Hospitals
6.4.3.5. Surgical Centers
6.4.3.6. Clinical research institutes

6.4.4. Japan IVF services market, by cycle type

6.4.4.1. Market size and forecast
6.4.4.2. Market volume and forecast
6.4.4.3. Fresh IVF cycles (non-donor)
6.4.4.4. Thawed IVF cycles (non-donor)
6.4.4.5. Donor egg IVF cycles

6.4.5. Market Dynamics

6.4.5.1. Driving Factors
6.4.5.2. Restraining Factors

6.4.6. Regulatory issues, legislations and authorities
6.4.7. Insurance reimbursement scenario
6.4.8. Company profile

6.4.8.1. IVF NAMBA Clinic

6.4.8.1.1. Company overview

6.4.8.2. Sanno Hospital

6.4.8.2.1. Company overview

6.4.8.3. Oak Medical Group/Oak Clinic

6.4.8.3.1. Company overview

6.5. Australia IVF Services Market, (Revenue and Number of Cycles)

6.5.1. Overview
6.5.2. Market size and forecast
6.5.3. Fertility center in Australia, 2017
6.5.4. Australia IVF Services Market, by end user

6.5.4.1. Market size and forecast
6.5.4.2. Market volume and forecast
6.5.4.3. Fertility clinics
6.5.4.4. Hospitals
6.5.4.5. Surgical Centers
6.5.4.6. Clinical research institutes

6.5.5. Australia IVF services market, by cycle type

6.5.5.1. Market size and forecast
6.5.5.2. Market volume and forecast
6.5.5.3. Fresh IVF cycles (non-donor)
6.5.5.4. Thawed IVF cycles (non-donor)
6.5.5.5. Donor egg IVF cycles

6.5.6. Market Dynamics

6.5.6.1. Driving Factors
6.5.6.2. Restraining Factors

6.5.7. Regulatory issues, legislations and authorities
6.5.8. Insurance reimbursement scenario
6.5.9. Company profile

6.5.9.1. Virtus Health

6.5.9.1.1. Company overview

6.5.9.2. Monash IVF Wesley Hospital Auchenflower

6.5.9.2.1. Company overview

6.5.9.3. Fertility First

6.5.9.3.1. Company overview

6.5.9.4. Flinders Reproductive Medicine Pty Ltd

6.5.9.4.1. Company overview

6.6. New Zealand IVF Services Market, (Revenue and Number of Cycles)

6.6.1. Overview
6.6.2. Market size and forecast
6.6.3. New Zealand IVF Services Market, by end user

6.6.3.1. Market size and forecast
6.6.3.2. Market volume and forecast
6.6.3.3. Fertility clinics
6.6.3.4. Hospitals
6.6.3.5. Surgical Centers
6.6.3.6. Clinical research institutes

6.6.4. New Zealand IVF services market, by cycle type

6.6.4.1. Market size and forecast
6.6.4.2. Market volume and forecast
6.6.4.3. Fresh IVF cycles (non-donor)
6.6.4.4. Thawed IVF cycles (non-donor)
6.6.4.5. Donor egg IVF cycles

6.6.5. Market Dynamics

6.6.5.1. Driving Factors
6.6.5.2. Restraining Factors

6.6.6. Regulatory issues, legislations and authorities
6.6.7. Insurance reimbursement scenario
6.6.8. Company profile

6.6.8.1. Fertility Associates

6.6.8.1.1. Company overview

6.6.8.2. Genea Oxford Fertility Limited

 
 

The adoption of IVF procedure is expected to increase in the near future due to rise in infertile population across the world and upsurge in fertility tourism in the developing countries. In addition, increase in success rate of IVF, surge in disposable income, and rise in trend of delayed pregnancies are expected to drive the market growth in the coming future. However, complications associated with the use of IVF and increase in procedure cost are expected to hinder the market growth.

Asia-Pacific is expected to dominate the IVF services market during the forecast period, followed by Europe. Emerging fertility tourism destinations such as India, Thailand, Japan, and Australia are chiefly responsible for the market growth in Asia-Pacific, due to the availability of skilled workforce and rise in healthcare awareness across these nations. In addition, rise in funding in R&D by government and private companies, introduction of fertility programs, and implementation of favorable regulatory policies for the development of IVF products are projected to supplement the growth of the European IVF services market. Efforts of Human Fertilisation and Embryology Authority (HFEA) and the acceptance of three parent IVF methods in countries, such as the UK, are further anticipated to support the growth of the Europe IVF services market.

Japan, China, U.S., India, and France are the prominent countries for IVF procedures. This is attributed to the affordability and reimbursements available for IVF cycles. Countries across Western Europe exhibit an alleviated response toward IVF procedures owing to favorable regulations and lesser ethical obligations. However, ethical issues and lack of regulatory policies hamper the growth of the IVF services market in Latin America and some parts of Middle East.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of IVF services market is $12,505.98 million in 2018.

A. The forcast period for IVF Services market is 2019 to 2026

A. The market value of IVF Services market in 2019 is $13,730.47 million

A. The base year is 2018 in IVF Services market

A. IVI RMA, Morpheus Life Sciences Pvt. Ltd., Virtus Health, and Heidelberg University Hospital are holding the major share in the IVF Services market in 2018

A. Thawed IVF cycle (non-donor) segment is the most influencing segment growing in the IVF Services market

A. Delayed in the pregnancies of women and increase in global infertility rates would help the market to grow in the near future.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging country such as India with a CAGR of 14.7%

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
IVF Services Market

  • Online Only
  • $4,537
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $5,041
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $7,449
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $8,468
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $11,809
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers